WNS (NYSE:WNS) had its price target raised by Cowen from $62.00 to $70.00 in a research note released on Friday, The Fly reports. They currently have an outperform rating on the business services provider’s stock.
Several other analysts also recently weighed in on WNS. Wedbush reissued an outperform rating and issued a $19.00 target price on shares of Entasis Therapeutics in a report on Tuesday, April 2nd. Zacks Investment Research downgraded Green Plains from a hold rating to a strong sell rating in a report on Thursday, June 27th. Cantor Fitzgerald boosted their target price on WNS from $63.00 to $68.00 and gave the company an overweight rating in a report on Friday. Finally, Barrington Research set a $68.00 target price on WNS and gave the company a buy rating in a report on Wednesday, July 3rd. Seven analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of Buy and a consensus price target of $67.86.
Shares of NYSE WNS opened at $62.86 on Friday. The stock has a market cap of $3.19 billion, a P/E ratio of 27.94, a price-to-earnings-growth ratio of 2.22 and a beta of 1.05. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.07 and a quick ratio of 2.07. The business’s 50-day simple moving average is $58.76. WNS has a 1 year low of $39.24 and a 1 year high of $63.52.
WNS (NYSE:WNS) last announced its quarterly earnings results on Thursday, July 18th. The business services provider reported $0.72 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.48 by $0.24. The company had revenue of $214.60 million during the quarter, compared to the consensus estimate of $207.51 million. WNS had a return on equity of 24.35% and a net margin of 13.44%. WNS’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.59 EPS. Equities analysts anticipate that WNS will post 2.3 earnings per share for the current year.
Several institutional investors have recently bought and sold shares of the company. Nkcfo LLC purchased a new stake in WNS during the 1st quarter valued at approximately $35,000. Migdal Insurance & Financial Holdings Ltd. raised its stake in WNS by 201.8% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 688 shares of the business services provider’s stock valued at $37,000 after acquiring an additional 460 shares during the last quarter. Diversified Trust Co purchased a new stake in WNS during the 1st quarter valued at approximately $211,000. Financial Gravity Wealth Inc. purchased a new stake in WNS during the 1st quarter valued at approximately $221,000. Finally, Confluence Investment Management LLC purchased a new stake in WNS during the 1st quarter valued at approximately $229,000. 94.14% of the stock is owned by institutional investors and hedge funds.
WNS (Holdings) Limited, a business process management company, together with its subsidiaries, provides data, voice, analytical, and business transformation services worldwide. It operates through two segments, WNS Global BPM and WNS Auto Claims BPM. The company offers industry-specific services to clients primarily in insurance; travel and leisure; diversified businesses, including manufacturing, retail, consumer packaged goods, media and entertainment, and telecommunication; utilities; consulting and professional services; healthcare; banking and financial services; and shipping and logistics industries.
See Also: Is it Safe to Invest in Commodities?
Receive News & Ratings for WNS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WNS and related companies with MarketBeat.com's FREE daily email newsletter.